Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer and Evaluation of βIII-Tubulin Expression as a Predictive Marker

BACKGROUND. This randomized phase II trial was designed to compare the rate of pathologic complete response (pCR) induced by neoadjuvant cyclophosphamide plus doxorubicin (AC) followed by ixabepilone or paclitaxel in women with early stage breast cancer (BC). Expression of βIII-tubulin as a predicti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Saura, Cristina, Tseng, Ling-Ming, Chan, Stephen, Chacko, Raju T., Campone, Mario, Manikhas, Alexy, Nag, Shona M., Leichman, Cynthia G., Dasappa, Lokanatha, Fasching, Peter A., Hurtado de Mendoza, Fernando, Symmans, W. Fraser, Liu, David, Mukhopadhyay, Pralay, Horak, Christine, Xing, Guan, Pusztai, Lajos
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2013
Assuntos:
Academia-Pharma Intersect: Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3720631/
https://ncbi.nlm.nih.gov/pubmed/23853246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0075
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados